Effects of Lixisenatide on Gastric Emptying, Glycaemia and 'Postprandial' Blood Pressure in Type 2 Diabetes and Healthy Subjects
Phase of Trial: Phase I/II
Latest Information Update: 02 Nov 2015
At a glance
- Drugs Lixisenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 07 Jun 2017 Biomarkers information updated
- 28 Oct 2015 Planned End Date changed from 1 Jun 2015 to 1 Apr 2016 as reported by ClinicalTrials.gov record.
- 28 Oct 2015 Planned primary completion date changed from 1 Jun 2015 to 1 Apr 2016 as reported by ClinicalTrials.gov record.